ArticleClinical and experimental medicine2024

GUCA2A dysregulation as a promising biomarker for accurate diagnosis and prognosis of colorectal cancer.

Pooya Jalali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.